Viehbacher, “Biogen”) announced today that humanized anti- soluble aggregated amyloid-beta (Aß) monoclonal antibody “LEQEMBI ® ” (generic name: lecanemab) has been approved for once every four weeks ...
Denarius Metals Corp. announced today that, as a result of strong investor demand, the Company has increased the size of its previously announced non-brokered private placement offering under the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback